
A US federal judge has ruled that the Association of Tennis Professionals (ATP Tour Inc.) cannot take retaliatory actions against individuals who may join an ongoing antitrust lawsuit alleging wage suppression and unfair treatment of players, according to Bloomberg.
The decision, issued by Judge Margaret M. Garnett in the Southern District of New York, partially granted a request from the plaintiffs to block the ATP Tour from further communication with potential class members. The plaintiffs argue that the organization engaged in behavior aimed at dissuading players from participating in the suit.
Per Bloomberg, the judge found that the ATP’s previous conduct, even if not deliberately malicious, could be interpreted by players as coercive or misleading. This raised concerns about the integrity of the legal process and the ability of potential class members to make informed, unpressured decisions regarding their participation in the litigation.
Read more: Players’ Association Sues Tennis Governing Bodies Over Alleged Antitrust Violations
The case centers on accusations that the ATP and other tennis entities conspired to suppress player earnings and limit opportunities through anticompetitive practices. While the court has not yet ruled on the merits of those claims, the order marks a significant development in how the case will proceed.
According to Bloomberg, the ruling means the ATP must refrain from direct contact that could influence the decisions of individuals eligible to join the lawsuit, reinforcing protections for players as the case moves forward.
Source: Bloomberg
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas